SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-002181
Filing Date
2014-01-14
Accepted
2014-01-14 16:24:44
Documents
5
Period of Report
2014-01-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v365385_8k.htm 8-K 16340
2 EXHIBIT 99.1 v365385_ex99-1.htm EX-99.1 20973
3 EXHIBIT 99.2 v365385_ex99-2.htm EX-99.2 23917
4 GRAPHIC image_001.jpg GRAPHIC 1658
5 GRAPHIC image_001.gif GRAPHIC 1128
  Complete submission text file 0001144204-14-002181.txt   66643
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 14527630
SIC: 2834 Pharmaceutical Preparations